2006
DOI: 10.1016/j.bmcl.2006.02.030
|View full text |Cite
|
Sign up to set email alerts
|

Antimalarial effect of bis-pyridinium salts, N,N′-hexamethylenebis(4-carbamoyl-1-alkylpyridinium bromide)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 35 publications
(13 citation statements)
references
References 5 publications
0
13
0
Order By: Relevance
“…General procedure for synthesis of quaternary pyridinium compounds Hydroxyiminomethylpyridine (1 mmol) and the alkylating agent (1.5 mmol) in solvent (20 mL) were stirred at 60-80°C for 1-24 h. The mixture was cooled to room temperature, the precipitate was collected, washed with acetone (3 · 20 mL), dried under vacuum, and characterized by 1 H NMR, 13 C NMR, ESI-MS and IR (19). Spectral data for representative compounds are as follows: (Bromothiophen-2-yl)-methyl-2-hydroxyiminomethylpyridinium chloride (1)(2)(3)(4)(5)(6)9), antimalarial (7,8,(10)(11)(12)(13)(14), and antileishmanial (15) pyridinium salts ⁄ dications.…”
Section: Methodsmentioning
confidence: 99%
“…General procedure for synthesis of quaternary pyridinium compounds Hydroxyiminomethylpyridine (1 mmol) and the alkylating agent (1.5 mmol) in solvent (20 mL) were stirred at 60-80°C for 1-24 h. The mixture was cooled to room temperature, the precipitate was collected, washed with acetone (3 · 20 mL), dried under vacuum, and characterized by 1 H NMR, 13 C NMR, ESI-MS and IR (19). Spectral data for representative compounds are as follows: (Bromothiophen-2-yl)-methyl-2-hydroxyiminomethylpyridinium chloride (1)(2)(3)(4)(5)(6)9), antimalarial (7,8,(10)(11)(12)(13)(14), and antileishmanial (15) pyridinium salts ⁄ dications.…”
Section: Methodsmentioning
confidence: 99%
“…[22] We reported N,N'-hexamethyleneA C H T U N G T R E N N U N G [bis(4-carbamoyl-1-octylpyridinium)] dibromide (PAM-86: 5), a potent antimalarial compound that can be synthesized inexpensively by using isonicotinic acid (11) as a starting material ( Figure 1). [23] Although the in vitro antimalarial activity of PAM-86 (5) was found to be as potent as that of chloroquine (1) (IC 50 was 10 nm when the FCR-3 strain was used as a malarial plasmodium), [23] the in vivo activity in mice was less potent than that of chloroquine (1) (unpublished data). In addition, it was difficult to modify the side-chain structure.…”
Section: Introductionmentioning
confidence: 99%
“…The first lead compounds, PAM-86 (Figure 7), exhibited promising antiplasmodial activities in vitro (IC 50 = 10 nm), but not in vivo. [74] The subsequently designed MAP series showed increased activities with increased alkyl chain linker length, whereas the cytotoxicity of the compounds increased with the number of side methylene groups (m). [75] A lead compound, MAP-412 (n = 12, m = 4; see Figure 7), exhibited an IC 50 value of 100 nm with no cytotoxicity and an ED 50 value of 8.2 mg kg À1 in mice infected with P. berghei.…”
mentioning
confidence: 99%